Condition
Stroke, Cryptogenic
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
P 2 (2)
P 4 (1)
Trial Status
Completed2
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07828210Phase 4Recruiting
NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic Stroke
NCT05289947Phase 2Completed
MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits
NCT06504121Completed
PFO tRanscatether Occlusion Long-term Outcomes National Group (PROLONG) Registry
NCT05046106Phase 2Not Yet Recruiting
MLC1501 Study Assessing Efficacy in STROke Recovery
Showing all 4 trials